TrialCancer chemotherapy and pharmacology2022
Exposure-response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma.
Anne-Gaëlle Dosne et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it